In short. Three families of device, matched to the three causes. Where pigment-directed, vessel-directed and resurfacing work reaches, and where each of them falls short.
Key points
- What is this aimed at: pigment, vessels, or texture?
- How deep is the problem, and does this device reach that depth?
- How many sessions, what downtime after each, and what maintenance afterwards?
Devices are not one category of treatment with different names. There are three families, each aimed at a different target: pigment, vessels, or surface geometry. Choosing between them is not a matter of which is stronger, because a device aimed at the wrong target is not weak, it is irrelevant. Cause comes first, then depth, then how much downtime the skin can accommodate.
Pigment-directed light and laser
These deliver energy absorbed by pigment and break up what is there, and the skin clears it over the following weeks. For sun-driven marks sitting high in the skin they are the most predictable option available, and they usually need more than one session. Their limits are specific. Pigment sitting deeper responds poorly however many sessions are given, and melasma is the pattern where they most often make things worse, because the melanocytes are already overactive. In skin that marks after injury, they can leave pigment in the place of what was removed.
Vessel-directed light
A different range is absorbed by haemoglobin rather than melanin, which makes it useful for fixed redness and visible surface vessels. It does not treat a tendency to flush, which is a response rather than a structure, and where flushing is present the medical management of that comes first. Reduction rather than clearance is the honest expectation, and new vessels can form, so maintenance is often part of the arrangement.
Peeling categories
Chemical peeling removes a controlled depth of surface. Superficial peels are staged over a series, produce limited flaking and gradually even out pigment. Medium-depth work reaches further at the cost of real peeling and redness. Deeper work carries the greatest effect and the greatest risk, including pigment change of its own in skin that marks easily.
Resurfacing for texture
Where the problem is surface geometry, the options work either by removing a layer of surface and letting the skin rebuild it, or by creating controlled injury beneath an intact surface. Ablative and non-ablative fractional approaches sit at different points on that spectrum, and microneedling, with or without radiofrequency energy, sits at the gentler end. All improve scars rather than removing them, and all carry a risk of pigment change in some skin types.
The question to ask before agreeing to any device
What is this aimed at: pigment, vessels, or texture? How deep is the problem, and does this device reach that depth? How many sessions, what downtime after each, and what maintenance afterwards? And what happens if my skin marks?
Where devices fall short
No device resets a face to a single uniform colour, and none removes the need for protection afterwards. A face re-exposed to sun between sessions is treated and undone at once, and for melasma the ceiling is lower still.
Walk away, or ask again, if
- A device is recommended before the category and depth are established.
- You are promised that a set number of sessions will clear the problem.
- A deep peel or aggressive resurfacing is proposed for melasma or for skin that marks easily.
Frequently asked questions
Why does the same laser not work for both brown patches and redness?
Because the two targets absorb different parts of the light. Brown patches are melanin, and the devices aimed at them deliver energy melanin absorbs. Redness is haemoglobin inside vessels, and it needs a different part of the spectrum that haemoglobin absorbs. Aiming a pigment-directed device at a vascular face leaves the vessels untouched while the skin still has to recover from the treatment.
Do I need several sessions, and what happens between them?
Usually yes, and the interval is part of the treatment rather than a delay. Between sessions the skin is clearing what was broken up, and how much it clears depends heavily on protection, because unprotected exposure in that window puts pigment back. Sessions are judged against standardised photographs rather than against how the face feels on a given morning.
How do I judge whether a device result was reasonable?
By whether the change matches what was promised before it started. Reduction and evening are reasonable outcomes; a single uniform colour is not, and no device produces it. If a face is darker or more irritated than before, or if the plan continues past the point where photographs show change, that is the point to stop and have the category and the depth reassessed.
Risks & Limitations
- Uneven tone is not one condition. Pigment, vessels and texture answer to different treatment, and a plan built on the wrong category can produce no change however long it is continued.
- Pigment that has faded returns with further unprotected sun exposure, and melasma relapses when control lapses. Maintenance is part of the result rather than evidence that treatment failed.
- Melasma is the pattern where aggressive treatment can leave skin darker rather than lighter; rebound darkening after high-energy pigment work is a recognised outcome, not a rare accident.
- No treatment resets skin to a single uniform colour. Tone can be reduced and evened, and pigment held deep in the dermis responds poorly to everything available.
When to Seek Care
- A mole or spot that is changing in size, shape or colour, or that itches, bleeds or fails to heal — have it examined rather than lightened.
- Darkening that has developed over weeks rather than years, or that appeared away from skin exposed to the sun — seek medical assessment.
- Darkening with tiredness, weight change, cold intolerance or dizziness, which may point to a hormonal or metabolic cause.
- Darkening with yellowing of the eyes or skin, dark urine or pale stools — seek medical assessment promptly.
References & Further Reading
- American Academy of Dermatology (AAD) — patient guidance on pigmentation disorders
- International League of Dermatological Societies (ILDS) — global standards of care
- National Institute for Health and Care Excellence (NICE, UK) — relevant guidance
- Cochrane Library — systematic reviews
- Chinese Medical Association Dermatology Branch — clinical guidance
This page is patient education, not medical advice, and it does not cite individual studies. Discuss your own case with a qualified clinician. To arrange an assessment at Chongqing West District Hospital, see Contact & Consultation.